Reversal of epigenetic promoter silencing in Friedreich ataxia by histone deacetylase inhibitors
Awardee: Yogesh Chutake
Institution: University of Oklahoma HSC
Award Amount: $35,000
Funding Period: January 1, 2015 - December 31, 2015
Previous
Previous
Pilot Study of the Efficacy and Safety of Sirolimus in the Treatment of Congenital Hyperinsulinism
Next
Next